Co-Authors
This is a "connection" page, showing publications co-authored by BITA ESMAELI and JAMES MATTHEW DEBNAM.
Connection Strength
4.160
-
Extrathyroidal Manifestations of Thyroid Disease: Graves Eye Disease. Neuroimaging Clin N Am. 2021 Aug; 31(3):367-378.
Score: 0.787
-
Rate of response to immune checkpoint inhibitor therapy in patients with conjunctival melanoma. Melanoma Res. 2024 Dec 06.
Score: 0.248
-
Graves' Eye Disease: Clinical and Radiological Diagnosis. Biomedicines. 2023 Jan 22; 11(2).
Score: 0.218
-
Multifocal recurrence of pleomorphic adenoma of the lacrimal gland. Am J Ophthalmol Case Rep. 2022 Sep; 27:101600.
Score: 0.208
-
Multidisciplinary Management of Orbital Metastasis and Survival Outcomes. Ophthalmic Plast Reconstr Surg. 2021 Nov-Dec 01; 37(6):541-545.
Score: 0.200
-
Primary Ewing's sarcoma with orbit involvement: Survival and visual outcomes after eye-sparing multidisciplinary management in eight patients. Head Neck. 2021 12; 43(12):3857-3865.
Score: 0.199
-
Immune checkpoint inhibitors for treatment of periorbital squamous cell carcinoma. Br J Ophthalmol. 2023 03; 107(3):320-323.
Score: 0.199
-
Frequency and Clinical Course of Residual Orbital Masses After Treatment of Orbital Rhabdomyosarcoma. Am J Ophthalmol. 2022 02; 234:28-36.
Score: 0.196
-
Primary disease sites and patterns of spread in cases of neurolymphomatosis in the orbit associated with lymphoma. Cancer Imaging. 2021 May 26; 21(1):39.
Score: 0.194
-
Characteristics and Survival Outcomes of Second Primary Cancers in Long-term Retinoblastoma Survivors. Asia Pac J Ophthalmol (Phila). 2021 Jan 19; 10(4):366-372.
Score: 0.190
-
Malignant Mixed Tumor (Carcinoma Ex Pleomorphic Adenoma) of the Lacrimal Gland. Ophthalmic Plast Reconstr Surg. 2020 Sep/Oct; 36(5):497-502.
Score: 0.185
-
Prognostic factors for local recurrence and survival and impact of local treatments on survival in lacrimal gland carcinoma. Br J Ophthalmol. 2021 06; 105(6):768-774.
Score: 0.183
-
Extraocular Muscle Enlargement and Thyroid Eye Disease-like Orbital Inflammation Associated with Immune Checkpoint Inhibitor Therapy in Cancer Patients. Ophthalmic Plast Reconstr Surg. 2019 Jan/Feb; 35(1):50-52.
Score: 0.164
-
Clinical Presentation and Anatomical Location of Orbital Plasmacytomas. Ophthalmic Plast Reconstr Surg. 2018 May/Jun; 34(3):258-261.
Score: 0.157
-
Clinical Course of Preseptal and Orbital Cellulitis in 50 Immunocompromised Patients with Cancer. Ophthalmology. 2018 02; 125(2):318-320.
Score: 0.152
-
A 60-year-old woman with an asymptomatic left lacrimal gland mass found incidentally. Digit J Ophthalmol. 2017; 23(4):27-29.
Score: 0.151
-
Three-Dimensional Multidetector CT for Anatomic Evaluation of Orbital Tumors. J Ophthalmol. 2013; 2013:674230.
Score: 0.115
-
Clinical value of magnetic resonance imaging and other baseline testing for conjunctival mucosa-associated lymphoid tissue lymphoma. Leuk Lymphoma. 2014 May; 55(5):1013-7.
Score: 0.114
-
Bone invasion by adenoid cystic carcinoma of the lacrimal gland: preoperative imaging assessment and surgical considerations. Ophthalmic Plast Reconstr Surg. 2010 Nov-Dec; 26(6):403-8.
Score: 0.093
-
Imaging characteristics of dacryocystocele diagnosed after surgery for sinonasal cancer. AJNR Am J Neuroradiol. 2007 Nov-Dec; 28(10):1872-5.
Score: 0.075
-
Rates of Positive Findings on Positron Emission Tomography and Bone Marrow Biopsy in Patients With Ocular Adnexal Lymphoma. Ophthalmic Plast Reconstr Surg. 2017 Sep/Oct; 33(5):355-360.
Score: 0.037
-
Imaging Features of Malignant Lacrimal Sac and Nasolacrimal Duct Tumors. AJNR Am J Neuroradiol. 2016 Nov; 37(11):2134-2137.
Score: 0.035
-
MRI findings of myocutaneous and fasciocutaneous flaps used for reconstruction of orbital exenteration defects. Ophthalmic Plast Reconstr Surg. 2014 Jul-Aug; 30(4):328-36.
Score: 0.030
-
Imaging findings of recurrent tumors after orbital exenteration and free flap reconstruction. Ophthalmic Plast Reconstr Surg. 2014 Jul-Aug; 30(4):315-21.
Score: 0.030